Skip to content

Contact +44 (0) 20 7060 7474 email us

Medical Devices

Global Cardiovascular Devices Pipeline Landscape

Analysis of Key Upcoming Products and Technologies

Publication Date January 2010
Publisher Globaldata
Product Type Report
Pages 111
ISBN Number not applicable
Product Code GDA00159

Price

£1,320.00
approximately: $1,999 | €1,473

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

While the leading cardiovascular device manufacturers continue to be impacted by economic and regulatory challenges, factors such as increasing Research and Development (R&D) costs, a shortening product pipeline and increasing competition from small and medium-sized companies are putting additional pressure on these manufacturers to stay competitive and remain profitable. Considering the ever-expanding competitive landscape, it is important to have a thorough analysis and intelligent insight on the key cardiovascular pipeline devices expected to bring in dynamism in the market.

GlobalData's new report, Global Cardiovascular Devices Pipeline Landscape:Analysis of Key Upcoming Products and Technologies provides key data, information and analysis on the key cardiovascular pipeline devices expected to hit the market in the next seven years. Cardiovascular devices remain a key segment within the medical equipment industry. This medical device report also provides information on the market potential, market scope and expected market penetration of these products. It also identifies and reviews the existing competing technologies and the likely impact of the launch on the competitive landscape.

  • This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

  • Annualized market revenues data from 2000 to 2009, forecast forward for seven years to 2016.
  • The report profiles each pipeline product with information on product description, features, benefits and advantages.
  • Pipeline product and market size information for the following categories - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Devices
  • The report analyses the safety and efficacy profile of each product vis--vis other competing products already in market.
  • The report covers information on product details, indication details and clinical trial status with projections on the market potential.
  • The report also reviews and analyses the trends shaping and defining the markets that the products are being targeted in.
  • Key topics covered in the report include the device-specific developments, M&A landscape and strategic partnerships expected to influence the launch and market penetration.
  • Key players covered include Medtronic, Cordis Corporation, St. Jude Medical, Boston Scientific Corporation and Abbott.

Reasons to buy:

  • Develop business strategies by understanding the trends and developments that are driving the cardiovascular devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • What's the next being thing in the cardiovascular devices technology landscape? - Identify, understand and capitalize.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

  • 1 Table of contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Global Cardiovascular Devices Market Overview
    • 2.1 Cardiovascular Devices, Global, Revenue ($m), Historic, 2000-2009
    • 2.2 Cardiovascular Devices, Global, Revenue ($m), Forecast, 2009-2016
    • 2.3 Global Cardiovascular Devices Market: Company Shares
  • 3 Cardiac Rhythm Management : Pipeline Landscape
    • 3.1 Cardiac Rhythm Management: Market Overview
      • 3.1.1 Cardiac Rhythm Management, Global, Revenue ($m), Historic, 2000-2009
      • 3.1.2 Cardiac Rhythm Management, Global, Revenue ($m), Forecast, 2009-2016
    • 3.2 Cardiac Rhythm Management: Market Dynamics
      • 3.2.1 Market Drivers
      • 3.2.2 Market Restraints
    • 3.3 Cardiac Rhythm Management: Technology Landscape
      • 3.3.1 MRI Compatible Cardiac Rhythm Management Devices
      • 3.3.2 EnRhythm MRI SureScan Pacing System
      • 3.3.3 Wireless Cardiac Stimulation Device
      • 3.3.4 Paradym sonR CRT- D
    • 3.4 Cardiac Rhythm Management Pipeline Product Summary
  • 4 Cardiovascular Monitoring and Diagnostic Devices: Pipeline Landscape
    • 4.1 Cardiovascular Monitoring and Diagnostic Devices: Market Overview
      • 4.1.1 Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), Historic, 2000-2009
      • 4.1.2 Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), Forecast, 2009-2016
    • 4.2 Cardiovascular Monitoring and Diagnostic Devices: Market Dynamics
      • 4.2.1 Market Drivers
    • 4.3 Cardiovascular Monitoring and Diagnostic Devices: Technology Landscape
      • 4.3.1 Leadless Cardiac Monitoring Device
    • 4.4 Cardiovascular Monitoring and Diagnostic Devices Pipeline Product Summary
  • 5 Cardiovascular Prosthetic Devices: Pipeline Landscape
    • 5.1 Cardiovascular Prosthetic Devices: Market Overview
      • 5.1.1 Cardiovascular Prosthetic Devices, Global, Revenue ($ m), Historic, 2000-2009
      • 5.1.2 Cardiovascular Prosthetic Devices, Global, Revenue ($ m), Forecast, 2009-2016
    • 5.2 Cardiovascular Prosthetic Devices: Market Dynamics
      • 5.2.1 Market Drivers
      • 5.2.2 Market Restraints
    • 5.3 Cardiovascular Prosthetic Devices: Technology Landscape
      • 5.3.1 AbioCor II
      • 5.3.2 3f Enable Aortic Valve
      • 5.3.3 Perceval S Sutureless Aortic Valve
      • 5.3.4 SAPIEN Transcatheter Heart Valve
      • 5.3.5 Melody Transcatheter Pulmonary Valve
    • 5.4 Cardiovascular Prosthetic Devices Pipeline Product Summary
  • 6 Cardiovascular Surgery: Pipeline Landscape
    • 6.1 Cardiovascular Surgery: Market Overview
      • 6.1.1 Cardiovascular Surgery, Global, Revenue ($ m), Historic, 2000-2009
      • 6.1.2 Cardiovascular Surgery, Global, Revenue ($ m), Forecast, 2009-2016
    • 6.2 Cardiovascular Surgery: Market Dynamics
      • 6.2.1 Market Drivers
      • 6.2.2 Market Restraints
    • 6.3 Cardiovascular Surgery: Technology Landscape
      • 6.3.1 CyberHeart System
    • 6.4 Cardiovascular Surgery Pipeline Product Summary
  • 7 Electrophysiology: Pipeline Landscape
    • 7.1 Electrophysiology: Market Overview
      • 7.1.1 Electrophysiology, Global, Revenue ($ m), Historic, 2000-2009
      • 7.1.2 Electrophysiology, Global, Revenue ($ m), Forecast, 2009-2016
    • 7.2 Electrophysiology: Market Dynamics
      • 7.2.1 Market Drivers
      • 7.2.2 Market Restraints
    • 7.3 Electrophysiology: Technology Landscape
      • 7.3.1 Sensei System for Atrial Fibrillation
    • 7.4 Electrophysiology Pipeline Product Summary
  • 8 Interventional Cardiology: Pipeline Landscape
    • 8.1 Interventional Cardiology: Market Overview
      • 8.1.1 Interventional Cardiology, Global, Revenue ($ m), Historic, 2000-2009
      • 8.1.2 Interventional Cardiology, Global, Revenue ($ m), Forecast, 2009-2016
    • 8.2 Interventional Cardiology: Market Dynamics
      • 8.2.1 Market Drivers
      • 8.2.2 Market Restraints
    • 8.3 Interventional Cardiology: Technology Landscape
      • 8.3.1 Bioabsorbable stents
      • 8.3.2 VestaSync
      • 8.3.3 Combo Bio-engineered Sirolimus Eluting Stent
      • 8.3.4 Intravascular Ultrasound
      • 8.3.5 AMPLATZER PFO Occluder - Migraine
    • 8.4 Interventional Cardiology Pipeline Product Summary
  • 9 Peripheral Vascular Devices: Pipeline Landscape
    • 9.1 Peripheral Vascular Devices: Market Overview
      • 9.1.1 Peripheral Vascular Devices, Global, Revenue ($ m), Historic, 2000-2009
      • 9.1.2 Peripheral Vascular Devices, Global, Revenue ($ m), Forecast, 2009-2016
    • 9.2 Peripheral Vascular Devices: Market Dynamics
      • 9.2.1 Market Drivers
      • 9.2.2 Market Restraints
    • 9.3 Peripheral Vascular Devices: Technology Landscape
      • 9.3.1 ZILVER PTX Drug Eluting Peripheral Stent
    • 9.4 Peripheral Vascular Devices Pipeline Product Summary
  • 10 Appendix
    • 10.1 Abbreviations
    • 10.2 Definitions
      • 10.2.1 Cardiovascular Devices
      • 10.2.2 Cardiac Rhythm Management
      • 10.2.3 Cardiovascular Monitoring and Diagnostic Devices
      • 10.2.4 Cardiovascular Prosthetic Device
      • 10.2.5 Cardiovascular Surgery
      • 10.2.6 Electrophysiology
      • 10.2.7 Interventional Cardiology
      • 10.2.8 Peripheral Vascular Devices
    • 10.3 Research Methodology
    • 10.4 Secondary Research
    • 10.5 Primary Research
    • 10.6 Models
    • 10.7 Forecasts
    • 10.8 Expert Panels
    • 10.9 GlobalData Consulting
    • 10.10 Contact Us
    • 10.11 Disclaimer
  • List of Tables
    • Table 1: Cardiovascular Devices, Global, Revenue ($ m), 2000-2009
    • Table 2: Cardiovascular Devices, Global, Revenue ($ m), 2009-2016
    • Table 3: Global Cardiovascular Devices Market, Company Shares, Revenue ($ m), 2008
    • Table 4: Cardiac Rhythm Management, Global, Revenue ($m), 2000-2009
    • Table 5: Cardiac Rhythm Management, Global, Revenue ($m), 2009-2016
    • Table 6: Paradym sonR CRT defibrillator, Europe, Revenue ($ m), 2009-2016
    • Table 7: Global Cardiac Rhythm Management Pipeline Product Summary - I
    • Table 8: Global Cardiac Rhythm Management Pipeline Product Summary - II
    • Table 9: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2000-2009
    • Table 10: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2009-2016
    • Table 11: Global Cardiovascular Monitoring And Diagnostic Devices Pipeline Product Summary - I
    • Table 12: Global Cardiovascular Monitoring And Diagnostic Devices Pipeline Product Summary - II
    • Table 13: Global Cardiovascular Monitoring And Diagnostic Devices Pipeline Product Summary - III
    • Table 14: Cardiovascular Prosthetic Devices, Global, Revenue ($ m), 2000-2009
    • Table 15: Cardiovascular Prosthetic Devices , Global, Revenue ($ m), 2009-2016
    • Table 16: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - I
    • Table 17: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - II
    • Table 18: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - III
    • Table 19: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - IV
    • Table 20: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - V
    • Table 21: Cardiovascular Surgery, Global, Revenue ($ m), 2000-2009
    • Table 22: Cardiovascular Surgery, Global, Revenue ($ m), 2009-2016
    • Table 23: Global Cardiovascular Surgery Pipeline Product Summary - I
    • Table 24: Global Cardiovascular Surgery Pipeline Product Summary - II
    • Table 25: Electrophysiology, Global, Revenue ($ m), 2000-2009
    • Table 26: Electrophysiology, Global, Revenue ($ m), 2009-2016
    • Table 27: Global Electrophysiology Pipeline Product Summary -I
    • Table 28: Global Electrophysiology Pipeline Product Summary -II
    • Table 29: Interventional Cardiology, Global, Revenue ($ m), 2000-2009
    • Table 30: Interventional Cardiology, Global, Revenue ($ m), 2009-2016
    • Table 31: Global Interventional Cardiology Pipeline Product Summary - I
    • Table 32: Global Interventional Cardiology Pipeline Product Summary - II
    • Table 33: Global Interventional Cardiology Pipeline Product Summary - III
    • Table 34: Global Interventional Cardiology Pipeline Product Summary - IV
    • Table 35: Global Interventional Cardiology Pipeline Product Summary - V
    • Table 36: Global Interventional Cardiology Pipeline Product Summary - VI
    • Table 37: Global Interventional Cardiology Pipeline Product Summary - VII
    • Table 38: Global Interventional Cardiology Pipeline Product Summary - VIII
    • Table 39: Global Interventional Cardiology Pipeline Product Summary - IX
    • Table 40: Global Interventional Cardiology Pipeline Product Summary - X
    • Table 41: Peripheral Vascular Devices, Global, Revenue ($ m), 2000-2009
    • Table 42: Peripheral Vascular Devices, Global, Revenue ($ m), 2009-2016
    • Table 43: Global Peripheral Vascular Devices Pipeline Product Summary - I
    • Table 44: Global Peripheral Vascular Devices Pipeline Product Summary - II
    • Table 45: Global Peripheral Vascular Devices Pipeline Product Summary - III
    • Table 46: Global Peripheral Vascular Devices Pipeline Product Summary - IV
    • Table 47: Global Peripheral Vascular Devices Pipeline Product Summary - V
  • List of Figures
    • Figure 1: Cardiovascular Devices, Global, Revenue ($m), 2000-2009
    • Figure 2: Cardiovascular Devices, Global, Revenue ($m), 2009-2016
    • Figure 3: Global Cardiovascular Devices Market, Company Shares (%), 2008
    • Figure 4: Cardiac Rhythm Management, Global, Revenue ($m), 2000-2009
    • Figure 5: Cardiac Rhythm Management, Global, Revenue ($m), 2009-2016
    • Figure 6: EnRhythm MRI SureScan pacing system: Features and Benefit Analysis
    • Figure 7: Wireless Cardiac Stimulation Device: Features and Benefit Analysis
    • Figure 8: Paradym sonR CRT-D: Features and Benefit Analysis
    • Figure 9: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2000-2009
    • Figure 10: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2009-2016
    • Figure 11: Leadless Cardiac Monitoring Device: Features and Benefit Analysis
    • Figure 12: Cardiovascular Prosthetic Devices, Global, Revenue ($ m), 2000-2009
    • Figure 13: Cardiovascular Prosthetic Devices , Global, Revenue ($ m), 2009-2016
    • Figure 14: AbioCor II: Features and Benefit Analysis
    • Figure 15: 3f Enable Aortic Valve: Features and Benefit Analysis
    • Figure 16: Perceval S Sutureless Aortic Valve: Features and Benefit Analysis
    • Figure 17: SAPIEN Transcatheter Heart Valve: Features and Benefit Analysis
    • Figure 18: Melody Transcatheter Pulmonary Valve: Features and Benefit Analysis
    • Figure 19: Cardiovascular Surgery, Global, Revenue ($ m), 2000-2009
    • Figure 20: Cardiovascular Surgery, Global, Revenue ($ m), 2009-2016
    • Figure 21: CyberHeart System: Features and Benefit Analysis
    • Figure 22: Electrophysiology, Global, Revenue ($ m), 2000-2009
    • Figure 23: Electrophysiology, Global, Revenue ($ m), 2009-2016
    • Figure 24: Sensei System for Atrial Fibrillation: Features and Benefit Analysis, 2010
    • Figure 25: Interventional Cardiology, Global, Revenue ($ m), 2000-2009
    • Figure 26: Interventional Cardiology, Global, Revenue ($ m), 2009-2016
    • Figure 27: Abbott Bioabsorbable Everolimus Eluting Coronary Stent: Features and Benefit Analysis, 2010
    • Figure 28: VestaSync: Features and Benefit Analysis, 2010
    • Figure 29: Combo Bio-engineered Sirolimus Eluting Stent: Features and Benefit Analysis, 2010
    • Figure 30: Comparison of Coronary Angiogram With Intra Vascular Ultrasound Image, 2010
    • Figure 31: Intra Vascular Ultrasound: Features and Benefit Analysis, 2010
    • Figure 32: AMPLATZER PFO Occluder-migraine: Features and Benefit Analysis, 2010
    • Figure 33: Peripheral Vascular Devices, Global, Revenue ($ m), 2000-2009
    • Figure 34: Peripheral Vascular Devices, Global, Revenue ($ m), 2009-2016
    • Figure 35: ZILVER PTX Drug Eluting Peripheral Stent: Features and Benefit Analysis, 2010
    • Figure 36: GlobalData Methodology